New Cancer Risk May be Linked to Mitoxantrone
Patients who use mitoxantrone appear to be at increased risk of colon cancer, according to a new study, and as well as acute myeloid leukemia (AML). Mitoxantrone is used to treat aggressive relapsing-remitting, and also progressive, MS when the patient doesn’t respond to other drugs. It suppresses the immune system and was first developed as a treatment for some cancers. Its use is limited because past studies have shown that…Continue Reading